Advertisement
News
Subscribe to MDT Magazine News

Diabetes-focused biotech Rhythm closes $40M Series A round

September 8, 2010 5:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Rhythm Pharmaceuticals Inc., a startup focused on obesity and diabetes treatments, had closed a $40 million Series A financing, funded by MPM Capital and Third Rock Ventures, both of Boston, as well as New Enterprise Associates of Maryland.

Streamline Health Document Workflow Solutions Purchased By Tampa, Florida-Based Hospital

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

CINCINNATI, Sept. 8 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ) a leading provider of document workflow solutions for hospitals, today announced that a leading Tampa, Florida-based medical institution has purchased three additional workflow licenses to expand the use of...

TOPICS:

STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

MONROVIA, Calif., Sept. 8 /- STAAR Surgical Company (Nasdaq: STAA ), the leading worldwide developer, manufacturer and marketer of phakic intraocular lenses, today announced that the Visian Implantable Collamer® Lens (ICL) was featured prominently in more than 40 presentations by...

TOPICS:
Advertisement

MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment in Open-Label Trial and Completion of Treatment in QT Trial for LEVADEX™ Clinical Program

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Sept. 8 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that all non-asthmatic patients and a subset of asthmatic patients have completed 12 months of treatment in the open-label safety trial of LEVADEX™. In addition, the Company has completed...

TOPICS:

Isis Pharmaceuticals to Present at the Stifel Nicolaus 2010 Healthcare Conference

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., Sept. 8 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Stifel Nicolaus' 2010 Healthcare Conference on Thursday, September 16, 2010 at 8:35 a.m. ET at The Four Seasons...

TOPICS:

MAP Pharmaceuticals Reports No Difference in Pulmonary Artery Pressure Between LEVADEX™ and Placebo in Pharmacodynamics Trial

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Sept. 8 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today reported results from a pharmacodynamics (PD) trial comparing the acute effects on pulmonary artery pressure of LEVADEX™, dihydroergotamine mesylate (DHE) administered intravenously (IV) and placebo....

TOPICS:

N30 Pharma Initiates Phase 1 Trials of Novel Reductase Inhibitor

September 8, 2010 3:33 am | by Bio-Medicine.Org | Comments

BOULDER, Colo., Sept. 8 /- N30 Pharmaceuticals, LLC today announced it has dosed the first human subject with N6022, a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR). N6022 is the first GSNOR inhibitor to be administered to human beings. N6022 has the potential to be...

TOPICS:

Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online

September 8, 2010 3:32 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., Sept. 8 /- Cardiogenesis Corporation (OTCQB: CGCP) today announced that the Wall Street Reporter has interviewed Cardiogenesis' Executive Chairman Paul J. McCormick.  The interview includes a discussion of the Company's results for the first half of 2010, including an...

TOPICS:
Advertisement

Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India

September 8, 2010 1:32 am | by Bio-Medicine.Org | Comments

India's rapid pharmaceutical market growth is being driven largely by branded generics. The market will generate nearly $8 billion in pharmaceutical sales this year, a number that is expected to more than double by 2015. Abbott expects its pharmaceutical sales in India to exceed $2.5...

Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics

September 8, 2010 1:32 am | by Bio-Medicine.Org | Comments

LONDON, Sept. 8 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the...

TOPICS:

American Society of Human Genetics to host 60th Annual Meeting in Washington, D.C.

September 7, 2010 9:34 pm | by EurekAlert | Comments

(American Society of Human Genetics) The world?s top scientists and clinicians in the human genetics field will gather in Washington, D.C., to present their latest research findings at the 60th Annual Meeting of the American Society of Human Genetics, from Tuesday, November 2,...

TOPICS:

New Chip Captures Specialized Immune Cells

September 7, 2010 8:31 pm | by Massachusetts Institute of Technology | Comments

The device could help scientists predict which patients are susceptible to serious infections.

TOPICS:

AngioDynamics 1Q results expected to be lower

September 7, 2010 3:45 pm | by The Associated Press | Comments

Medical device maker AngioDynamics Inc. gave preliminary results for its fiscal first quarter Tuesday that fell short of Wall Street expectations, as sales were hurt by a slowdown in medical procedures.The company said earnings were 7 cents to 8 cents per share, compared with 9 cents per share...

NIH renews Baylor College of Medicine grant for Human Microbiome Project program at Texas Children's Hospital

September 7, 2010 2:33 pm | by Baylor College of Medicine | Comments

The National Institutes of Health today announced expanded funding of the Baylor College of Medicine Human Microbiome Project clinical program initiated last year at Texas Children's Hospital . The program will receive $3.4 million over three years to broaden the current study of...

TOPICS:

Sparks Will Fly at Weld Trials Competition at 2010 FABTECH Show in Atlanta

September 7, 2010 10:39 am | by Society of Manufacturing Engineers | Comments

MIAMI, FLA., September 2, 2010 — The top six finalists selected from 24 student welders that competed in the SkillsUSA Championships 2009 and 2010 will be showcased at the 2010 Weld-Off Competition sponsored by the American Welding Society at the FABTECH show Nov. 2-4, in Atlanta. More

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading